Novo Nordisk stock at DKK 253.00 on September 25, 2026
Published on 09/28/2026 at 21:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Novo Nordisk shares closed at DKK 253.00 on Nasdaq Copenhagen on September 25, 2026, according to MarketScreener. The quoted daily change was 0.00 percent. Novo Nordisk’s B shares trade in Copenhagen under Novo-B, while the company’s American depositary receipts trade separately in New York.
Share repurchase program
In a September 21 release, GlobeNewswire reported that Novo Nordisk had repurchased 34,174,179 B shares since February 4, 2026. The purchases had a total transaction value of DKK 9,629,922,935 and an average price of DKK 281.79 per share as of September 18.
The company’s overall repurchase program allows purchases of up to DKK 15 billion over 12 months beginning February 4, 2026. A subprogram initiated May 6 allows purchases of up to DKK 11,200,000,010.45 through February 1, 2027, according to the same release.
EASD 2026 presentations
Novo Nordisk said in a September 16 GlobeNewswire release that it planned to present 44 abstracts at the European Association for the Study of Diabetes meeting in Milan from September 28 through October 2. The planned material covers semaglutide, CagriSema, zenagamtide and other cardiometabolic research, including real-world data on the Wegovy pill.
